Chesnara Plc: Fourth acquisition in two years
12 November 2026
Embecta Corp. (NASDAQ: EMBC) is making waves in the healthcare sector, particularly for investors focused on the medical instruments and supplies industry. This U.S.-based company, with..
AbCellera Biologics Inc. (NASDAQ: ABCL), a prominent player in the biotechnology sector, presents a fascinating opportunity for investors drawn to the healthcare industry. Headquartered in Vancouver,..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is capturing the attention of investors with its groundbreaking work in cell and exosome-based therapeutics, particularly for..
Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to targeting fibroblast growth factor receptor..
Vir Biotechnology, Inc. (NASDAQ: VIR) is garnering significant attention in the investor community, particularly due to its impressive potential upside of 121.51%. This clinical-stage biopharmaceutical company,..
Investors eager to tap into the burgeoning healthcare sector may find Talkspace, Inc. (NASDAQ: TALK) an intriguing prospect. As a virtual behavioral healthcare provider, Talkspace connects..
Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage precision medicines company, is capturing investor attention with its notable potential upside and unanimous buy ratings from analysts. Specializing..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands out in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $1.55..
Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company headquartered in Tübingen, Germany, is capturing investor attention with its promising position in the dynamic biotechnology industry. Specializing..
Definitive Healthcare Corp. (NASDAQ: DH) presents a compelling opportunity for investors seeking potential high returns in the healthcare sector. Despite its current challenges, the company’s strategic..
Arvinas, Inc. (NASDAQ: ARVN) is making waves in the biotechnology sector with its innovative approach to drug development, focusing on the degradation of disease-causing proteins. As..
Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a significant player in the healthcare sector, specifically within the drug manufacturing industry focusing on specialty and generic..
Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, is attracting significant attention in the biotechnology industry with its promising pipeline and remarkable potential upside. Situated..
Cogent Biosciences, Inc. (NASDAQ: COGT) is garnering significant attention in the biotechnology sector, with a market capitalization of $5.62 billion. As a clinical-stage biotechnology company, Cogent..
Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector, is drawing investor attention with a significant potential upside of 56.38%. With its focus..
Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company based in San Diego, is making waves in the biotechnology industry with its innovative approach to cancer..
Bicycle Therapeutics plc (NASDAQ: BCYC) emerges as a captivating prospect for investors seeking opportunities in the rapidly evolving biotechnology sector. With a market cap of $315.62..
As the world continues to focus on innovative healthcare solutions, AnaptysBio, Inc. (NASDAQ: ANAB) stands out as an intriguing prospect in the biotechnology industry. With a..
Immunome, Inc. (NASDAQ: IMNM) has captured the attention of the investment community with its compelling growth narrative in the healthcare sector. Specializing in biotechnology, this U.S.-based..
For investors with a keen eye on the biotechnology sector, Savara, Inc. (NASDAQ: SVRA) presents a compelling opportunity. With a market capitalization of $1.06 billion, this..
